Fulvestrant Injection (FULBRECA 250MG Injection)

Piece

4.5 (154)

11,000

Fulbreca 250mg Injection is an estrogen receptor blocker used for the treatment of breast cancer in postmenopausal women. It works by reducing the activity of estrogen on breast cancer cells, which helps slow down or stop their growth and spread. This medicine may help relieve symptoms such as breast lumps and other cancer-related changes. It is administered as an intramuscular injection by a healthcare professional under medical supervision as prescribed by the doctor.

Description

Introduction Of Fulbreca 250mg Injection:

Fulbreca 250mg Injection is an estrogen blocker. It is utilized in the therapy of breast cancer in ladies who have gone through menopause. It works by changing the degree of estrogen and dial back the development of cancer cells.

FULBRECA 250mg Injection is given as an infusion into the muscles under the management of a specialist. It ought to be taken as specialist your primary care physician’s recommendation. The portion and how frequently you take it relies upon what you are taking it for. Your primary care physician will conclude the amount you really want to work on your side effects. You ought to take this medication however long it is recommended for you.

Uses Of Fulbreca 250mg Injection:

  • Breast cancer

Benefits Of Fulbreca 250mg Injection:

In Breast cancer

FULBRECA 250mg Injection lets the side effects free from breast malignant growth, for example, breast irregularities, horrendous release from areola or changes in the shape or surface of the breast. It works by modifying the development of those chemicals in the body that are fundamental for the development and spread of breast cancer. It might likewise interface with different chemicals or straightforwardly affect the cancer to stop its development. It is given as an infusion by a specialist or medical caretaker and ought not to be self-controlled. Adhere to your doctor directions cautiously.

Mechanism Of Action Of Fulbreca 250mg Injection:

Fulbreca 250 mg Injection hinders the activity of estrogen on breast malignant growth cells. This can lower or stop the development of a breast cancer cells that need estrogen to develop.

Contact Us

Info Table
Packaging Size 5 ml in 1 vial
Manufacturer Alkem Laboratories Ltd
Brand Fulvetraz 250mg Injection
Composition Fulvestrant 250mg
Packaging 250mg
Treatment Breast cancer
Prescription/Non prescription Prescription
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of Fulbreca 250mg Injection:

Fulbreca 250mg Injection is an estrogen blocker. It is utilized in the therapy of breast cancer in ladies who have gone through menopause. It works by changing the degree of estrogen and dial back the development of cancer cells.

FULBRECA 250mg Injection is given as an infusion into the muscles under the management of a specialist. It ought to be taken as specialist your primary care physician’s recommendation. The portion and how frequently you take it relies upon what you are taking it for. Your primary care physician will conclude the amount you really want to work on your side effects. You ought to take this medication however long it is recommended for you.

Uses Of Fulbreca 250mg Injection:

  • Breast cancer

Benefits Of Fulbreca 250mg Injection:

In Breast cancer

FULBRECA 250mg Injection lets the side effects free from breast malignant growth, for example, breast irregularities, horrendous release from areola or changes in the shape or surface of the breast. It works by modifying the development of those chemicals in the body that are fundamental for the development and spread of breast cancer. It might likewise interface with different chemicals or straightforwardly affect the cancer to stop its development. It is given as an infusion by a specialist or medical caretaker and ought not to be self-controlled. Adhere to your doctor directions cautiously.

Mechanism Of Action Of Fulbreca 250mg Injection:

Fulbreca 250 mg Injection hinders the activity of estrogen on breast malignant growth cells. This can lower or stop the development of a breast cancer cells that need estrogen to develop.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Fulvestrant Injection (FULBRECA 250MG Injection)”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Fulbreca 250mg Injection?
Fulbreca 250mg Injection contains fulvestrant, an estrogen receptor antagonist. It is a prescription medicine used under medical supervision for certain hormone-receptor-positive breast cancers. Fulvestrant works by blocking the action of estrogen on certain breast cancer cells.
Fulbreca 250mg Injection is used for certain types of hormone-receptor-positive, advanced or metastatic breast cancer. The specific indication and whether it is used alone or with other medicines depend on the patient’s condition and treatment plan.
Fulbreca 250mg Injection is administered slowly into the muscle of the buttocks by a doctor or nurse. Fulvestrant is generally given according to a scheduled treatment regimen determined by the treating healthcare professional.
Patients should inform their doctor about allergies, liver disease, bleeding problems, pregnancy or plans to become pregnant, breastfeeding, and all medicines or supplements they are taking. Particular attention may be required when using blood-thinning medicines such as warfarin.
Possible side effects may include nausea, vomiting, constipation, diarrhea, abdominal pain, headache, hot flashes, tiredness, muscle or joint pain, and pain or swelling at the injection site. Serious symptoms such as difficulty breathing, chest pain, severe allergic reactions, or yellowing of the skin or eyes require prompt medical attention.
For additional information about fulvestrant, including its uses, administration, precautions, interactions, and possible side effects, visit MedlinePlus Drug Information. Patients should consult their oncologist or healthcare professional for advice specific to their treatment.

Related products